Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TROXYCA ER

NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE

Standard Dose
1.2MG;10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary

Approval overview TROXYCA ER is listed in Drugs@FDA under application 207621 (NDA).

Review priority: N/A Marketing status: Discontinued Active ingredient NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 1.2MG;10MG Sponsor PFIZER Submission history Latest submission status date: 2017-05-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview TROXYCA ER is listed in Drugs@FDA under application 207621 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 1.2MG;10MG Sponsor PFIZER Submission history Latest submission status date: 2017-05-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.